Wenli L. Li

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Lipid droplet associated protein HILPDA promotes hypoxia-induced ferroptosis by driving LPCAT3-mediated polyunsaturated phospholipids enrichment.

Lipid droplet associated protein HILPDA promotes hypoxia-induced ferroptosis by driving LPCAT3-mediated polyunsaturated phospholipids enrichment.

Journal: PloS one

Published: December 22, 2025

Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances.

Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances.

Journal: CNS neuroscience & therapeutics

Published: December 17, 2025

DHA and EPA exacerbate hypoxia-induced ferroptosis in gastric and small intestinal mucosa by disrupting the balance between SLC7A11 upregulation and PUFA-PL accumulation.

DHA and EPA exacerbate hypoxia-induced ferroptosis in gastric and small intestinal mucosa by disrupting the balance between SLC7A11 upregulation and PUFA-PL accumulation.

Journal: Journal of lipid research

Published: April 05, 2025

Involvement of expanded cytotoxic and proinflammatory CD28null T cells in primary Sjögren's syndrome.

Involvement of expanded cytotoxic and proinflammatory CD28null T cells in primary Sjögren's syndrome.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 30, 2023

The role of imbalanced CD226/TIGIT on activated peripheral double-negative T cells in the pathogenesis of primary Sjögren's syndrome.

The role of imbalanced CD226/TIGIT on activated peripheral double-negative T cells in the pathogenesis of primary Sjögren's syndrome.

Journal: Clinical and experimental rheumatology

Published: October 05, 2023

Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.

Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.

Journal: Rheumatology (Oxford, England)

Published: March 28, 2023

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.

Journal: RMD open

Published: October 23, 2022

Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.

Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.

Journal: BMC musculoskeletal disorders

Published: November 20, 2021

Clinico-pathological and follow-up analysis of 5 skeletal muscle single-organ vasculitis cases

Clinico-pathological and follow-up analysis of 5 skeletal muscle single-organ vasculitis cases

Journal: Zhonghua yi xue za zhi

Published: March 25, 2021

The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study.

The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study.

Journal: Frontiers in pharmacology

Published: November 30, 2020

Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.

Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.

Journal: Arthritis research & therapy

Published: September 10, 2020

Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.

Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.

Journal: Journal of autoimmunity

Published: March 15, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026